Dr. rer. nat. Dipl. Ing. Matthias Goßmann holds a diploma in biotechnology and a doctorate degree in chemistry. Since 2008, he has been working on the development of a new technology to measure cardiac contraction force within a flexible environment. He gained 3.5 years of experience as senior scientist in the stem cell industry, before starting his own business as one of the two founders of innoVitro, in 2017. innoVitro’s main focus is the product of his doctorate degree project: The FLEXcyte 96 Service, a cardiac contractility assay co-developed with Nanion Technologies.